Insulin-like growth factor (IGF)-binding proteins (IGFBPs) potently modulate the interactions of IGF-I and -II with the IGF-I receptor.
Previous studies have shown that IGFBP2 gene expression is localized in astroglia, where it is anatomically and temporally coordinated with neuronal IGF-I expression during postnatal brain development. The present study shows that IGFBP5 gene expression is also highly abundant during brain development and also demonstrates significant spatiotemporal correlation with IGF-I, but exhibits a neuroanatomical distribution that is entirely distinct from IGFBPP. IGFBP5 and IGF-I mRNAs are synchronously coexpressed in principal neurons of sensory relay systems, including the olfactory bulb, medial and dorsal lateral geniculate bodies, and ventral tier, cochlear, lemniscal, and vestibular nuclei. They are also transiently coexpressed in principal neurons of the anterodorsal nucleus, but IGF-I mRNA disappears from this structure shortly after birth, while IGFBPS mRNA remains highly abundant here in the adult. IGFBP5 and IGF-I gene expression demonstrate a temporally coordinated laminar association in the developing cerebellar cortex and hippocampal formation. IGF-I mRNA is concentrated in Purkinje cells, while IGFBP5 mRNA is localized in the external germinal zone in the developing cerebellar cortex. IGFBP5 mRNA is transiently expressed in the retrosplenial and cingulate cortex, subiculum, Ammon's horn, and amygdala, while IGF-I mRNA is contemporaneously localized in large interneurons distributed throughout the hippocampal formation.
IGFBPB mRNA is localized in the lateral ventricular germinal zone at birth and remains in the subventricular zone into maturity. It is also detected in forebrain white matter tracts and olfactory nerve from the second week after birth into maturity.
Thus IGFBPS, in addition to IGFBPP, may be a significant determinant of IGF action in the brain. Colocalization in some sites and paralocalization with IGF-I in other sites suggests the potential for autocrine and paracrine interaction between the binding protein and IGF-I in different settings. Arguments are advanced suggesting a role for IGFBPs in the targeting Received Feb. 19, 1993; revised May 21, 1993; accepted June 15, 1993. We are grateful to Peter Rotwein for supplying us with the IGFBPS clone prior to publication and to Ricardo Dreyfuss and John Ward for expert photography. Insulin-like growth factors I and II (IGF-I and -II) are anabolic peptides that are present in the circulation and that are also synthesized locally in a variety of tissues, including the brain. IGF-I demonstrates a highly distinctive pattern of gene expression during brain development (Bondy, 199 1) . It is concentrated in the large principal neurons of sensory and cerebellar projection systems, with peak expression during a late stage of development characterized by growth of neuronal soma and processes. IGF-I's actions are mediated by the IGF-I receptor, which is a membrane-bound, ligand-activated tyrosine kinase homologous to the insulin receptor. This receptor is widely expressed throughout the brain, as revealed by ligand-binding studies (Sara et al., 1982; Bohannon et al., 1988; Lesniaket al., 1988; Werther et al., 1989) and in situ hybridization (Marks et al., I99 1; Bondy et al., 1992a,b) . It is particularly abundant in the brain regions and cells where IGF-I is synthesized, suggesting a local autocrine or paracrine mode of action for neuronal IGF-I (Bondy et al., 1992a) . This view is supported by the localization of IGF-I immunoreactivity in the immediate vicinity of cellular sites of synthesis (Andersson et al., 1988) . The function of IGF-I synthesized by these neurons is not known, but based upon significant parallelism between the pattern of IGF-I receptor distribution and patterns of brain metabolic activity as revealed by glucose uptake and protein synthesis, it has been suggested that IGF-I may be an endogenous regulator of neural metabolism .
In the circulation and bodily fluids, the IGFs are complexed with high-affinity IGF-binding proteins (IGFBPs), of which six structurally and genetically related species have been characterized (reviewed by Clemmons, 1990; Rosenfeld et al., 1990; Rechler and Brown, 1992) . These IGFBPs bind IGFs with significantly greater affinity than does the IGF-I receptor and are synthesized in different tissues in concert with local IGF-I or -11 synthesis, where they are thought to modulate IGF action in the autocrine or paracrine setting. A number of different IGFBPs have been found in cultured neural tissues and cerebrospinal fluid (Haselbacher and Humbel, 1982; Han et al., 1988; Ocrant et al., 1990; Olson et al., 1991; Roghani et al., 1991) . We have recently shown that IGFBP2 gene expression is concentrated in astroglia in temporal and anatomical contiguity with neuronal IGF-I gene expression . For example, in the cerebellar cortex, IGFBP2 mRNA is localized in Bergmann radial glia adjacent to IGF-I-synthe-of Neuroscience, December 1993. 13(12) 5093 sizing Purkinje cells . IGFBP2 mRNA is also abundant in the choroid plexus and meninges in association with IGF-II (Tseng et al., 1989; Wood et al., 1990; Lee et al., 1992a Lee et al., ,b, 1993 . The present work extends our study of IGF system gene expression during rat brain development to IGFBPS. In this study, serial brain sections from the time of birth through postnatal day 60 (P60) were hybridized to cRNA probes for IGF-I, IGFBP2, IGFBPS, and the IGF-I receptor in order to delineate neuroanatomical patterns of IGFBPS gene expression and their spatiotemporal relationship to the other elements of the IGF constellation.
Materials and Methods
Timed-pregnant SpragueDawley rats were obtained from Taconic Farms (Germantown, NY). All animals were maintained in accordance with NIH guidelines for the care and use of laboratory animals, provided with standard rat chow and water ad libitum, and placed on a 12: 12 hr light/dark cycle. All pups were born in house and kept with the mother until death by decapitation following carbon dioxide anesthesia. Three to five brains were evaluated at each of the following time points: the day of birth (Pl), P5, P12, and P20. One or two brains were evaluated at P40, P60, and P90. All brains were immediately removed and snap frozen in isopentane and then stored at -70°C. Coronal sections of 10 pm thickness were cut through the entire rostral-caudal extent of the brain at -1 Y'C, thaw-mounted onto poly-L-lysine-coated slides, and stored at -70°C until hybridization. Rat IGF-I, IGF-I receptor, and IGFBP-2, and murine IGFBPS cDNA clones were used for the synthesis of cRNA probes, and each has been described in detail previously (Zhou and Bondy, 1993) . YS-labeled antisense and sense riboprobes were synthesized in 10 pl of reaction mixture containing 100 &i each of 35S-CTP and )S-UTP (New England Nuclear), 10 mM NaCl, 6 mM MgCl,, 40 mM Tris (pH 7.5) 2 mM spermidine, 10 mM dithiothreitol (DTT), 500 PM each unlabeled ATP and GTP, 25 FM each unlabeled UTP and CTP, 1 pg of linearized template, 15 U of the appropriate polymerase (Bethesda Research Labs) and 15 U of RNasin (Promega). The reaction was incubated at 42°C for 60 min, after which the DNA template was removed by digestion with DNase I. Average specific activity of probes generated by this protocol was 2.5 x lo8 dpm/pg.
Prior to hybridization, tissue sections were warmed to 25"C, fixed in 4% formaldehyde, and acetylated in 0.25% acetic anhydride, 0.1 M triethanolamine hydrochloride, 0.9% NaCl. Tissue was dehydrated through an ethanol gradient, delipidated in chloroform, rehydrated, and air dried. YS-labeled cRNA probes were added to fresh hybridization buffer (10' cpm/ml) composed of 50% formamide, 0.3 M NaCl, 20 mM Tris HCl (pH S), 5 mM EDTA, 500 pg oftRNA/ml, 10% dextran sulfate, 10 mM DTT, and 0.02% each of BSA, ficoll, and polyvinylpyrollidone. Hybridization buffer was added to sections, which were then covered with glass coverslips and placed in humidified chambers overnight (14 hr) at 55°C. Slides were washed several times in 4 x saline-sodium citrate (SSC) to remove coverslips and hybridization buffer, dehydrated, and immersed in 0.3 M NaCl. 50°Yo formamide. 20 mM Tris HCl. 1 mM EDTA at 60°C for 15 min. Sections were then treated with RHase A (20 &ml; Boehringer Mannheim, Indianapolis, IN) for 30 min at 37°C and passed through graded salt solutions, followed by a 15 min wash in 0.1 x SSC at 50°C. Slides were dehydrated, air dried, and apposed to Hyperfilm-beta Max (Amersham) for l-5 d, and then dipped in Kodak NTB3 nuclear emulsion, stored with desiccant at 4°C for 3-l 5 d, developed, and stained with cresyl violet or hematoxylin and eosin for microscopic evaluation. Each cRNA probe produced a specific and different pattern of hybridization in brain tissues. The level of nonspecific signal, as determined by hybridization of parallel tissue sections with a sense probe synthesized from the IGFR-I clone, was minimal.
Results while IGF-I but not IGFBPS mRNA is also localized in tufted cells (seen as multiple concentric rings of hybridization vs. the single ring representing the mitral cell layer for IGFBPS in Fig.  1 ). IGFBP2 mRNA is diffusely expressed throughout the olfactory bulb, although it is more heavily concentrated in the mitral cell layer. Previous studies have shown that IGFBP2 mRNA is localized in astrocytes, and is particularly abundant in those adjacent to IGF-I-expressing projection neurons . During postnatal maturation of the olfactory bulb, IGFBPS gene expression exhibits significant changes in intensity and in cellular distribution while IGF-I remains essentially unchanged (Fig. 1) . IGFBPS mRNA levels decrease in the mitral cell layer, and increase in the olfactory nerve layer and in the granule cell layer. The increased levels of IGFBPS mRNA in glial cells of the olfactory nerve are particularly striking.
Thalamus Figure 2 compares IGFBPS, IGF-I, anad IGFBP2 gene expression in the anterior thalamus on P 12. Most notably, IGFBPS and IGF-I mRNAs are colocalized in the anterodorsal nucleus. In terms of other components of the anterior thalamic nuclear complex, IGFBPS mRNA is present at low levels in the anteroventral nucleus, where IGF-I mRNA is not detected, while IGF-I mRNA is concentrated in the mediolateral nucleus, where IGFBPS is not detected (Fig. 2) . IGFBPS gene expression continues to be highly abundant in the anterodorsal nucleus at the latest developmental stage examined (P60), while IGF-I gene expression is barely detectable in the anterior thalamus after the third postnatal week. IGFBPS mRNA is also localized in the suprachiasmatic nucleus from PI 2 ( Fig. 2A) into adulthood. IGFBP2 mRNA is concentrated in the anterior thalamic nuclear complex, but is more diffusely expressed than IGF-I or IGFBPS, as is typical of the pattern of IGFBP2 expression in astroglia. IGFBPS mRNA is also localized in the subventricular zone of the lateral ventricles, and to a lesser extent in the white matter tracts flanking the ventricles ( Fig. 2A) .
IGFBPS and IGF-I mRNAs are detected in the ventral tier nuclei from approximately El 8 (not shown). Figure 3 shows the postnatal course of IGFBPS gene expression in these nuclei and compares IGFBPS with IGF-I, IGFBP2, and the IGF-I receptor at P12. IGFBPS mRNA levels remain high in the ventroposterolateral and ventroposteromedial nuclei and dorsolatera1 geniculate from birth through P 12, but are greatly reduced by P60 (Fig. 3,4-C) . IGFBPS and IGF-I mRNAs are colocalized in the projection neurons of the ventral tier and dorsolateral geniculate nuclei (Figs. 3, 4A-D) . IGFBP2 mRNA is concentrated in these same centers, but is localized in astroglia (Figs. 30, 4E, F) . IGFBPS, IGF-I, and IGFBP2 gene expression exhibit the same pattern in the development of the medial geniculate nucleus. IGFBPS mRNA localization in this auditory projection center is demonstrated in Figure 5 , while IGF-I and IGFBP2 have been previously described (Bondy, 1991; . The temporal pattern of IGFBPS gene expression in all of these sensory projection centers parallels that of IGF-I and IGFBP2 (Bondy, 1991; Lee et al., 1992b Lee et al., , 1993 present sion declines very soon after birth in all these structures except for the ventral subiculum, where it is localized in an irregular array of pyramidal cells (Fig. 6G) . IGFRPS gene expression appears in the granule cells of the dentate gyrus after the second postnatal week, during the time when it is declining elsewhere (Figs. 3, 5) . IGF-I mRNA is localized in large intemeurons dispersed throughout the hippocampus and IGFBP2 in hippocampal astroglial .
Cerebellum
From just before birth (E20), IGFBPS mRNA is localized in a number of small (non-Purkinje) cells dispersed through the cerebellar anlage, and in cells in the external germinal zone (Fig.  64 . At E20 and Pl, IGFBPS mRNA is present in the full thickness of the external zone (Fig. 6,4-C) . From P5 to P12, IGFRPS mRNA is detected in cells situated in the most super- ficial zone of the external granule cell layer, but not in the deeper cortex. By P20, the external granule cell layer is entirely depleted zone where granule cells are verging on the molecular layer ( Fig. and IGFBPS mRNA is greatly reduced throughout the cerebellar 6D,E). During this period, IGFBPS mRNA remains detectable cortex. IGFBPS mRNA appears in granule cells of the internal in the small nondescript cells scattered throughout the cerebellar granule cell layer during the third week after birth (not shown), rigwe 5. IGFBPS gene expression in he medial geniculate nucleus and venral hippocampal formation during mostnatal brain development. These matomically matched coronal sections were hybridized, washed, and exposed ogether. The PI2 section has a pituiary gland attached to the base of the n-sin. For abbreviations, see Appenlix.
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Fgure 6. IGFBPS mRNA (E20-P20, A-F) and in large neurons of the adult ventral subiculum (G) and P5 neocottex (IO. A shows a sagittal section through the cerebellar anlage from an E20 fetus. The choroid plexus of the fourth ventricle is at the lower right. B shows a sagittal section from a PI cerebellum, photographed at the same magnification as A. and C shows the same PI section at a higher magnification. All the photomicrographs in this figure are double-exposure bright and dark field taken with a green filter, so the hybridization signal appears as green grains. For abbreviations, see Appendix. S&e arrowheods (F) point to Purkinje cells; friple arrowheads (H) indicate a vertical column or chain of IGFBPS mRNA-expressing neurons spanning cortical layers 3 and 4 (layers 2 and 5 are labeled in H for reference). Scale bar: 100 Frn for A and B; 50 pm for C-F; 20 rrn for G and H. demonstrating a delayed time course and low level of expression similar to that seen in the granule cells of the olfactory bulb and dentate gyrus. IGFBPS mRNA is abundant in large neurons populating the deep cerebellar nuclei from Pl ( Fig. 6B ) through P12. IGF-I mRNA is also concentrated in these deep cerebellar neurons (Bondy, 199 1) .
Isocortex
IGFBPS gene expression demonstrates a laminar pattern in some regions of the frontoparietal cortex during the first postnatal week (Figs. 6H, 7) . It is localized in relatively large, pyramidallike cells that span layers 3-5, and in many areas the cells appear to be vertically aligned (Fig. 6H ). There is no apparent relationship between IGFBPS and IGF-I expression in the isocortex. IGF-I mRNA is contained in large intemeurons that are widely distributed throughout all regions and layers (Bondy, 199 1; Lee et al., 1993) . These cells are so large and the mRNA so abundant that the IGF-I hybridization signal from individual cells is visible on film autoradiographs (Figs. 2B, 3E ).
Other sites 3A-C, 7, 8) . IGFBPS mRNA was also detected in brainstem reticular and tegmental nuclei, but these structures were not studied systematically. The time course and neuroanatomical distribution of IGFBPS gene expression during rat brain development are summarized in Table 1 .
Discussion
Among the six high-affinity IGFBPs that have been identified to date, IGFBP2 and IGFBPS are most prominently expressed in the brain and both show peak gene expression in the brain parenchyma coinciding with peak IGF-I gene expression, that is, during the first 2 postnatal weeks. However, these two IGFbinding proteins demonstrate distinct neuroanatomical patterns and relationships to neuronal IGF-I gene expression. IGFBP2 mRNA is concentrated in astroglial cells adjacent to IGF-Iexpressing projection neurons in the retina, cerebellar cortex, and sensory relay centers . IGFBPS mRNA, as shown in the present study, is colocalized with IGF-I in the projection neurons of sensory relay systems, and is paralocalized in hippocampal and cerebellar laminar neurons. In addition, IGFBPS mRNA is expressed in neuroepithelial germinal zones and forebrain white matter tracts in apparent dissociation from local IGF-I production. The IGFBPs are soluble proteins that are constitutively secreted in tandem with their synthesis, as are IGF-I and -11. IGFBPs synthesized and secreted from the liver bind IGFs in the systemic circulation and serve to prolong IGF half-life. Certain IGFBPs may facilitate the transfer of IGFs from the circulation into tissue compartments (Bar, 1990) . The role of IGFBPs that are synthesized in specific tissues in conjunction with local IGF synthesis is not understood at present. A number of factors determine whether IGFBPs will have an inhibitory or facilitory impact upon IGF interaction with the IGF-I receptor in vitro. These conditioning factors include the phosphorylation and multimerization state of the IGFBP, the association of IGFBP with the cell surface or extracellular matrices, and the relative amounts of IGF versus IGFBP (reviewed in Clemmons, 1990) . How these factors might pertain to the in vivo situation where IGF and IGFBP are synthesized and secreted by the same or neighboring cells has not been ascertained.
IGFBPS mRNA is coexpressed with IGF-I in principal neurons of most but not all major sensory projection centers, that is, mitral cells, medial and dorsolateral geniculate bodies, and cochlear, vestibular, superior olivary, and ventral tier nuclei. IGFBPS mRNA is not detected, however, in the piriform cortex or anterior pretectal nucleus, while IGF-I mRNA is abundant in these sites (Bondy, 1991) . IGF-I gene expression also tracks cerebellar relay stations, including inferior olives, Purkinje cells, and deep cerebellar and red nuclei but not the pontine nuclei, while IGFBPS mRNA is detected in the inferior olivary and deep cerebellar and pontine nuclei, but not Purkinje cells or red nucleus. During the analysis of the pattern of IGF-I gene expression during postnatal brain development, it was noted that there were significant omissions or gaps in the chain of expression in these functionally related projection systems, for example, the pontine nuclei, in the case of cerebellar transmission. Now it is found that IGFBPS fills in these missing links. The significance of this patchwork pattern of IGF system expression in sensory and cerebellar projection networks is not understood at present.
IGFBPS gene expression traces nearly all elements of the hippocampal formation as well as many components of the limbic system during postnatal brain development. It is expressed in pyramidal cells of Ammon's horn during the first weeks after birth, at which time IGF-I mRNA is localized in large interneurons in the strata flanking the pyramidal layer . IGFBPS mRNA is localized in both the dorsal and ventral subiculum, and is especially prominent in the latter, where it remains relatively abundant in the adult. It is also localized in the amygdala, retrospenial and cingular cortex, and anterodorsal nucleus of the thalamus-coexpressed with IGF-I in the latter. IGF-I but not IGFBPS mRNA is concentrated in septal and diagonal band nuclei (Bondy, 199 l) , and both are expressed in the olfactory system. Continued high levels of IGF-I and IGFBPS gene expression are present in the olfactory system in the adult, and IGFBPS mRNA levels remain high in the anterodorsal nucleus, ventral subiculum, and dentate gyrus. Thus, the IGF system, represented by IGF-I or IGFBPS, demonstrates a pervasive presence throughout the limbic as well as sensory and cerebellar projection systems.
The IGF system constellation is most definitively characterized in the developing cerebellar cortex (diagrammed in Fig. 9 ). IGF-I is localized in Purkinje cells and IGFBP2 in Bergmann glial cells. The timing of IGF-I and IGFBP2 gene expression in these particular cells parallels the appearance and disappearance of the external granule cell layer, commencing around the time of birth and receding by P20 (Bondy, 1991; Lee et al., 1992b) . IGFBPS mRNA is localized in germinal cells of the external granule cell layer, in laminar apposition to Purkinje dendrites and Bergmann radial fibers. IGFBPS gene expression in these cells is correlated with their proliferative index. Perinatally, all the cells of external granule cell layer appear immature and demonstrate DNA synthesis, and all express IGFBPS mRNA, but by a few days after birth, proliferating cells are found only in the most superficial layer, while cells in the deeper layers exhibit morphological signs of differentiation and begin the process of migration through the molecular layer (Fujita et al., 1966) . The postmitotic granule cells of the deep layer of the external zone and cells migrating through the molecular layer do not demonstrate IGFBPS mRNA, but the more external cells in the germinal zone do. IGF-I immunoreactivity is abundant in the molecular layer of the developing cerebellar cortex (Andersson et al., 1988) . It is not detected in the most external cells of the external granular cell layer but is found in cells of the deeper zone and in migrating granule cells. This finding suggests that expression of IGFBPS by cells in the external zone may prevent the receptor-mediated internalization of IGF-I released from Purkinje dendrites. IGF-I immunoreactivity is also localized in Bergmann radial fibers, suggesting that expression of IGFBP2 is not incompatible with internalization (after colchitine, it is detected only in Purkinje cells; Andersson et al., 1988) . Not shown in the diagram is the fact that IGF-I receptor mRNA is detected in all the cell types present in the developing cerebellar cortex (Bondy et al., 1992a) .
IGFBPS mRNA is localized in forebrain ventricular and subventricular germinal zones during a time in which these zones give rise to olfactory granule cells in a pattern analogous to that seen in the secondary germinal zone in the cerebellar cortex. IGFBPS mRNA is detected in cells in the germinal zone but not in postmitotic, migratory granule cells on their way into the olfactory bulb and not in young granule cells in the olfactory bulb. Later, in both the olfactory bulb and cerebellar cortex (and dentate gyrus), mature granule cells display low levels of IGFBPS mRNA.
Finally, IGFBPS mRNA is expressed in some glial cell populations. It is localized in cells dispersed throughout the cere- bellar cortex from before birth to about P12. Since migration from the external germinal zone does not begin until a few days after birth (Fujita et al., 1966) these cells must have originated from periventricular germinal zones and thus are likely to be glial precursor cells (cerebellar neurons other than Purkinje cells arise from the external germinal zone). IGFBPS mRNA is also present in cells localized in forebrain white matter tracts, most abundantly in the olfactory nerve. Given this distribution, it is likely that these IGFBPS-expressing cells are oligodendrocytes or oligodendrocyte precursors; future studies employing immunological markers will be necessary to identify more clearly the IGFBPS-expressing cells of the cerebellar plate and white matter zones.
The striking spatiotemporal correlation between IGF-I and IGFBP2 and -5 gene expression in the developing brain suggests that these IGFBPs are important determinants of IGF-I action in CNS maturation. As far as is known, IGF-I and -11 are secreted constitutively and there is no evidence for packaging of IGFs into specialized secretory vesicles that would serve to store or transport the peptides to targeted release sites. Analysis of available immunocytochemical data coupled with our in situ hybridization results suggests that IGF-I is released from neuronal soma and processes close to synthesis sites. IGF-I receptor gene expression is very widespread throughout the CNS from earliest development, in a pattern that appears to be constitutive (Bondy et al., 1992a; Bondy and Lee, 1993) . Given the apparent lack of spatiotemporal focus of IGF action at the level of secretion and receptor expression, the expression of specific IGFBPs by different cells types in the vicinity of IGF-I-producing neurons may serve to target or quench IGF action with respect to these sites, thus adding a layer of regulation operative in the extracellular space between the site of secretion and reception. 
